Iyer, Kali R.
Camara, Kaddy
Daniel-Ivad, Martin
Trilles, Richard
Pimentel-Elardo, Sheila M.
Fossen, Jen L.
Marchillo, Karen
Liu, Zhongle
Singh, Shakti
Muñoz, José F. http://orcid.org/0000-0003-4987-7957
Kim, Sang Hu http://orcid.org/0000-0003-0597-0623
Porco, John A. Jr. http://orcid.org/0000-0002-2991-5680
Cuomo, Christina A. http://orcid.org/0000-0002-5778-960X
Williams, Noelle S.
Ibrahim, Ashraf S. http://orcid.org/0000-0003-3787-8530
Edwards, John E. Jr.
Andes, David R.
Nodwell, Justin R. http://orcid.org/0000-0001-7909-1803
Brown, Lauren E. http://orcid.org/0000-0001-9489-484X
Whitesell, Luke
Robbins, Nicole
Cowen, Leah E. http://orcid.org/0000-0001-5797-0110
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI141202)
U.S. Department of Health & Human Services | National Institutes of Health (R01AI073289, GM111615, GM118173)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 8 October 2020
Accepted: 12 November 2020
First Online: 22 December 2020
Competing interests
: L.E.C. and L.W. are co-founders and shareholders in Bright Angel Therapeutics, a platform company for development of novel antifungal therapeutics. L.E.C. is a consultant for Boragen, a small-molecule development company focused on leveraging the unique chemical properties of boron chemistry for crop protection and animal health. The remaining authors declare no competing interests.